Bayer will pay up to $7.25 billion over two decades to settle thousands of U.S. claims alleging its Roundup weed killer causes non-Hodgkin lymphoma.
The settlement, approved by a Missouri judge, covers both people already diagnosed and those who develop the disease in future years after exposure to Roundup.
The big picture: Individuals cou...